Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Latest filing published 30 Sept 2026 for Mitie Group PLC, €7.9M. Read the official filing
Filing timeline
BuySalePeter Dickinson
Insider track record
Disclosed buys
0
Disclosed sells
8
Signal history
Closed purchases
Market purchases
7
Positive at T+90
83%
Median T+90
+4.8%
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +16.7%Entry £1.80 · Close 30 Sept 2026 £2.10
- +7.3%Entry £1.48 · Close at T+90 £1.59
- +48.0%Entry £1.17 · Close at T+365 £1.73
- +25.0%Entry £1.18 · Close at T+365 £1.47
- +14.7%Entry £1.02 · Close at T+365 £1.17
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Peter Dickinson: trading record in brief
This profile gathers the share dealings of Peter Dickinson in Mitie Group PLC. We count 25 filings; the first trade dates from 29 June 2023 and the latest from 30 September 2026.
The open-market record consists of 8 sales worth €18.8M, with no purchase. The rest of the record consists of 12 share grants and 5 option exercises. In 2026 alone, the filings show no purchases and 3 sales.
Ninety days after publication, 6 purchases show a median change of +4.8%, with the price up in 83% of them. These figures describe past trades and do not predict future prices.
On 30 September 2026 came the latest disclosure, an open-market sale for €7.9M in Mitie Group PLC. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for notifying a trade is three business days (UK MAR). Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Peter Dickinson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
3,217,770 shares@ £2.10XLONISIN GB0004657408FCA-NSM:8a5d2595-c8be-489b-ae23-b2a0dfa34871
46,164 shares@ £2.0880.0036% mcap2.8% of flowXLONISIN GB0004657408FCA-NSM:07cb26a3-c914-4fec-8041-d299e1478425-1
Canonical exit: 25 Nov 2026 (T+90)
2,178,718 sharesXLONISIN GB0004657408FCA-NSM:d675fde9-7371-4609-b45e-b1161345abe9-0
858,698 sharesXLONISIN GB0004657408FCA-NSM:d675fde9-7371-4609-b45e-b1161345abe9-2
2,178,718 shares@ £2.08590.17% mcap71.7% of flowXLONISIN GB0004657408FCA-NSM:d675fde9-7371-4609-b45e-b1161345abe9-1
858,698 shares@ £2.08590.066% mcap28.3% of flowXLONISIN GB0004657408FCA-NSM:d675fde9-7371-4609-b45e-b1161345abe9-3
425,958 sharesOUTSIDE A TRADING VENUEISIN GB0004657408RNS:2ba872de-09d7-4616-8034-4525b25d4801-1
425,958 sharesOUTSIDE A TRADING VENUEISIN GB0004657408RNS:9635143-1
23,560 shares@ £1.8341.2% of flowXLONISIN GB0004657408RNS:8a3dfdf4-306d-43a5-b317-35466a049951-1
Canonical exit: 21 May 2026 (T+90)
48,883 shares@ £1.45342.0% of flowXLONISIN GB0004657408RNS:5774177-1
Canonical exit: 4 Nov 2025 (T+90)
620,644 sharesOUTSIDE A TRADING VENUEISIN GB0004657408RNS:5705774-1
609,588 shares@ £1.391624.8% of flowXLONISIN GB0004657408RNS:5705455-1
1,293,103 sharesXLONISIN GB0004657408RNS:5705455-0
28,223 shares@ £1.15721.0% of flowXLONISIN GB0004657408RNS:5529754-1
Canonical exit: 6 May 2025 (T+90)
175,000 shares@ £1.1646.0% of flowXLONISIN GB0004657408RNS:5513681
68,531 shares@ £1.16182.3% of flowXLONISIN GB0004657408RNS:5297954-1
Canonical exit: 3 Nov 2024 (T+90)
200,000 shares@ £1.2247.3% of flowXLONISIN GB0004657408RNS:5287572
761,096 shares@ £1.150625.9% of flowXLONISIN GB0004657408RNS:5231368-1
1,062,124 sharesXLONISIN GB0004657408RNS:5231368-0
681,166 sharesOUTSIDE A TRADING VENUEISIN GB0004657408RNS:5227835
22,588 shares@ £1.03390.7% of flowXLONISIN GB0004657408RNS:5056745-1
Canonical exit: 30 Apr 2024 (T+90)
839,836 shares@ £1.020625.0% of flowXLONISIN GB0004657408RNS:4897147-1
1,781,524 sharesOUTSIDE OF A TRADING VENUEISIN GB0004657408RNS:4897147-0
29,375 shares@ £1.03240.9% of flowXLONISIN GB0004657408RNS:4860853-0
Canonical exit: 2 Nov 2023 (T+90)
880,716 sharesOUTSIDE A TRADING VENUEISIN GB0004657408RNS:4821442-2
25 of 25 declarations
